|
Form Serial Number: |
DA20231110E00238
|
1.
Date of relevant event: |
07/11/2023 (dd/mm/yyyy)
|
2.
Date when director became aware of the relevant event/ interest in the shares (if later): |
(dd/mm/yyyy)
|
3.
Stock code: |
02269 |
4.
Name of listed corporation: |
WuXi Biologics (Cayman) Inc. |
5.
Class of shares: |
Ordinary Shares |
6.
Number of issued shares in class: |
4,253,512,049 |
7.
Name of director (English) as printed on HKID Card/Passport: |
(Surname) |
Zhou |
(Other names) |
Weichang |
|
|
|
10.
Name of director (Chinese): |
周偉昌 |
11.
Chinese Character Code as printed on HKID Card: |
|
|
24.
Details of relevant event: |
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved
|
Currency of transaction |
On Exchange
|
Off Exchange
|
Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Consideration code
|
Long position |
1303 | There has been a change in nature of your interest in the shares because: you have exercised rights to the shares under equity derivatives | |
|
|
500,000 |
HKD |
|
|
1.2933 |
|
Short position |
|
|
|
|
|
|
|
|
|
|
|
25.
Total shares in listed corporation immediately before the relevant event: |
| Total number of shares | Percentage figure (%) |
Long position | 17,300,439 | 0.41 |
|
|
26.
Total shares in listed corporation immediately after the relevant event: |
| Total number of shares | Percentage figure (%) |
Long position | 17,300,439 | 0.41 |
|
|
27.
Capacity in which interests disclosed in Box 26 are held: |
Code describing capacity | Number of shares |
| |
|
|
28.
Further information in derivative interests in listed corporation : |
Derivatives code |
Exercise period (dd/mm/yyyy) |
Consideration - if derivatives granted by listed corporation |
Number of shares |
| | Begins | Ends | Currency | Price for grant | Currency | Exercise price | Currency | Price on assignment | |
Long position | 4105 | Unlisted derivatives - Physically settled |
| 07/01/2016 | 06/01/2026 | HKD | 1 | USD | 0.167 | | | 12,096,000 |
Long position | 4105 | Unlisted derivatives - Physically settled |
| 15/03/2017 | 14/03/2027 | HKD | 1 | USD | 0.340 | | | 2,493,000 |
Long position | 4108 | Unlisted derivatives - Other (you must describe the category of derivatives in the Supplementary Information box) |
| 05/06/2021 | 05/06/2024 | | | | | | | 189,408 |
Long position | 4108 | Unlisted derivatives - Other (you must describe the category of derivatives in the Supplementary Information box) |
| 12/11/2022 | 12/11/2025 | | | | | | | 282,910 |
Long position | 4108 | Unlisted derivatives - Other (you must describe the category of derivatives in the Supplementary Information box) |
| 16/06/2023 | 16/06/2026 | | | | | | | 210,944 |
Long position | 4108 | Unlisted derivatives - Other (you must describe the category of derivatives in the Supplementary Information box) |
| 10/06/2024 | 10/06/2027 | | | | | | | 450,281 |
Long position | 4108 | Unlisted derivatives - Other (you must describe the category of derivatives in the Supplementary Information box) |
| 10/06/2023 | 10/06/2024 | | | | | | | 298,416 |
Long position | 4108 | Unlisted derivatives - Other (you must describe the category of derivatives in the Supplementary Information box) |
| 24/08/2025 | 24/08/2028 | | | | | | | 241,642 |
Long position | 4108 | Unlisted derivatives - Other (you must describe the category of derivatives in the Supplementary Information box) |
| 24/08/2024 | 24/08/2025 | | | | | | | 325,385 |
|
|
29.
Further information in relation to interests of children under 18 and/or spouse: |
Child/Spouse | Name of child/spouse | Number of shares |
| | |
|
|
30.
Further information in relation to interests of corporations controlled by Director: |
Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
| | | | | |
|
|
31.
Further information in relation to interests held by Director jointly with another person: |
Name of joint shareholder | Address | Number of shares |
| | |
|
|
32.
Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust: |
Names of Trust | Address | Status code | Number of shares |
| | | |
|
|
33.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
Names of other parties | Address | Number of shares |
| | |
Total number of shares in which a director is interested under sections 317 and 318 | |
|
|
34.
Supplementary information: |
Box 28: Represents the restricted shares granted to Dr. Zhou pursuant to the Restricted Share Award Scheme and the Share Award Scheme for Global Partner Program adopted by the Company on 15/01/2018 and 16/06/2021 (both amended and restated on 27/06/2023), respectively, and such restricted shares were approved and granted on 05/06/2019, 09/06/2020 (later granted on 12/11/2020), 16/06/2021, 10/06/2022 and 24/08/2023, respectively
|
35.
Log/Serial Number of the previous form: |
|
36.
Number of concert party document(s) under section 317 attached/uploaded: |
0
|
Date of filing this Form 3A: |
10/11/2023 (dd/mm/yyyy)
|
|